Southeast University
Also known as: Chun Pan | Department of Critical Care Medicine, Nanjing Zhong-da Hospital, School of Medicine, Southeast University | Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University | Genshan Ma | Ge Zheng | Jianfeng Xie | Medical School of South East University, China | Nanjing Chest Hospital, Medical School of Southeast University | Nanjing Zhong-Da Hospital, Southeast University | School of Biological Science and Medical Engineering, Southeast University | School of Bioscience & Medical Engineering, Southeast University | southeast univerity, China | Southeast University | Southeast University Affiliated Zhongda Hospital | Southeast University, China | southeast university zhongda hospitial | the chief of the neurology department, Zhongda Hospital of Southeast University | the Second Affiliated Hospital of Southeast University | The Second Affiliated Hospital of the Southeast University, Nanjing, China | Yuejiang Liu | Zhongda Hospital | Zhongda Hospital, Medical School, Southeast University | Zhongda Hospital, School of Medicine, Southeast Univerty | Zhongda Hospital, School of Medicinr, Southeast Univerty | Zhongda Hospital Southeast University | Zhongda hospital, Southeast university, Nanjing, China
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2008Last known activity
Dec 1, 2025
Timeline
1900s
- Jun 1, 1902
Southeast University— Founded
Drugs by trial phase (124 distinct, 96 trials)
Phase 4 (46 own, 0 via acquisition)
Phase 3 (26 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (24 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Adrenal Insufficiency
- Atrial Fibrillation
- Carcinoma
- Carcinoma, Hepatocellular
- Cognitive Dysfunction
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Critical Illness
- Delirium
- Dementia
- Dementia, Vascular
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Disseminated Intravascular Coagulation
- Heart Diseases
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hypertension
- Infarction
- Infections
- Kidney Diseases
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Malaria
- Myocardial Infarction
- Myocardial Ischemia
- Osteoarthritis
- Osteoarthritis, Knee
- Postoperative Complications
- Postoperative Pain
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pregnancy Complications
- Renal Insufficiency, Chronic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinal Diseases
- Rheumatic Heart Disease
- Sepsis
- Shock
- Shock, Septic
- ST Elevation Myocardial Infarction
- Syndrome
- Toxemia
- Viremia
Recent trials (50)
- NCT07311915Lead sponsorN/ADec 1, 2025
- NCT07311915Sponsor investigatorN/ADec 1, 2025
- NCT07164794Lead sponsorPhase 2Nov 30, 2025
- NCT07164794Sponsor investigatorPhase 2Nov 30, 2025
- NCT07187284Sponsor investigatorPhase 1/Phase 2Sep 30, 2025
- NCT07187284Lead sponsorPhase 1/Phase 2Sep 30, 2025
- NCT07012785Lead sponsorN/AJun 30, 2025
- NCT07012785Sponsor investigatorN/AJun 30, 2025
- NCT06939829Lead sponsorPhase 4May 1, 2025
- NCT06939829Sponsor investigatorPhase 4May 1, 2025
- NCT06939829OfficialPhase 4May 1, 2025
- NCT07163910Lead sponsorPhase 2Apr 20, 2025
- NCT07163910Sponsor investigatorPhase 2Apr 20, 2025
- NCT06900543OfficialPhase 3Apr 15, 2025
- NCT06861166Sponsor investigatorPhase 2/Phase 3Mar 10, 2025
Details
- Founded
- Nanjing, CN Jun 1, 1902
- Last known activity
- Dec 1, 2025